Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 925 of 2228 entries
View as:

Linagliptin and Metformin Versus Linagliptin in Newly Diagnosed, Untreated Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01512979 Org: User:
Start: 01/31/12 End: 04/30/13 Due: 04/30/14

The Primary Objective of This Study is to Determine Whether MICARDIS® Improves Insulin Sensitivity in Overweight or Obese, Non-diabetic, Normotensive Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00146289 Org: User:
Start: 02/28/05 End: - Due: -

Capsaicin + Diclofenac Gel in Acute Back Pain or Neck Pain

Phase: N/A Priority: Normal
NCT ID: NCT02700815 Org: User:
Start: 05/09/16 End: 07/21/17 Due: 07/21/18

Post Marketing Surveillance (PMS) Study to Assess Safety and Efficacy of Micardis in Patients With Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT02245464 Org: User:
Start: 11/30/00 End: - Due: -

Assessment of Exposure of BI 409306 in Cerebrospinal Fluid (CSF) Relative to Plasma as Well as to Evaluation of the Effect of Different Doses of BI 409306 on the cGMP (Cyclic Guanosine Monophosphate) Levels in CSF in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01493570 Org: User:
Start: 12/01/11 End: 02/21/12 Due: 02/21/13

30 Week Parallel Group Comparison Study of Linagliptin + Pioglitazone (5+15, 5+30 and 5+45 mg) qd Versus Respective Monotherapies, Followed by a Comparison of 5mg+30mg and 5mg+45mg Versus Respective Monotherapies in Type 2 Diabetes for up to 54 Weeks

Phase: N/A Priority: Normal
NCT ID: NCT01183013 Org: User:
Start: 08/31/10 End: 02/28/13 Due: 02/28/14

Overnight Switch Trial From Pramipexole IR to Pramipexole ER in Patients With Early Parkinson Disease

Phase: N/A Priority: Normal
NCT ID: NCT00558025 Org: User:
Start: 10/31/07 End: - Due: -

Effects of Tiotropium on Breathing Capacity and Exercise Limitation in Early Stages of Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT01072396 Org: User:
Start: 02/28/10 End: 11/30/11 Due: 11/30/12

Phase I Dose Escalation Trial of Volasertib in Combination With Azacitidine in Patients With MDS or CMML

Phase: N/A Priority: Normal
NCT ID: NCT01957644 Org: User:
Start: 11/06/13 End: 12/16/16 Due: 12/16/17

Afatinib (BIBW2992) in HER2 (Human Epidermal Growth Factor Receptor 2)-Overexpressing Inflammatory Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01325428 Org: User:
Start: 08/31/11 End: 11/30/14 Due: 11/30/15

EARLY 3-months Aggrenox Treatment Started Within 24 Hrs of Ischemic Stroke Onset vs. After One Week 100 mg ASA

Phase: N/A Priority: Normal
NCT ID: NCT00562588 Org: User:
Start: 07/31/07 End: - Due: -

Bioequivalence of a Fixed Dose Combination Tablet Linagliptin/Pioglitazone Compared With Its Mono-components

Phase: N/A Priority: Normal
NCT ID: NCT01276327 Org: User:
Start: 01/31/11 End: - Due: -

Tiotropium + Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 1)

Phase: N/A Priority: Normal
NCT ID: NCT01964352 Org: User:
Start: 11/30/13 End: 11/30/14 Due: 11/30/15

BI 811283 in Various Solid Tumours

Phase: N/A Priority: Normal
NCT ID: NCT00701324 Org: User:
Start: 06/30/07 End: 05/31/11 Due: 05/31/12

Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate

Phase: N/A Priority: Normal
NCT ID: NCT00262600 Org: User:
Start: 12/31/05 End: - Due: -

FLOMAX® Versus HYTRIN® in Patients With the Signs and Symptoms of Benign Prostatic Hyperplasia

Phase: N/A Priority: Normal
NCT ID: NCT02244255 Org: User:
Start: 08/31/98 End: - Due: -

Tipranavir/Ritonavir vs. Genotypically Defined Protease Inhibitor/Ritonavir in HIV Patients (RESIST-2)

Phase: N/A Priority: Normal
NCT ID: NCT00144170 Org: User:
Start: 02/28/03 End: - Due: -

Safety of Total Daily Doses of Polyethylene Glycol (PEG) 400 Administered Orally to Healthy Male Human Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02260076 Org: User:
Start: 09/30/01 End: - Due: -

Safety And Efficacy of BIBF 1120 in Idiopathic Pulmonary Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT00514683 Org: User:
Start: 08/31/07 End: - Due: -

A Study in Healthy Men to Test How BI 764198 is Processed in the Body

Phase: N/A Priority: Normal
NCT ID: NCT05863130 Org: User:
Start: 05/03/23 End: 11/09/23 Due: 11/09/24

A Study to Test How Well Healthy Men and Women Tolerate Different Doses of BI 706321

Phase: N/A Priority: Normal
NCT ID: NCT04241458 Org: User:
Start: 01/30/20 End: 11/25/20 Due: 11/25/21

SATisfaction and Adherence to COPD Treatment

Phase: N/A Priority: Normal
NCT ID: NCT02689492 Org: User:
Start: 12/11/15 End: 09/15/17 Due: 09/15/18

Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT01431287 Org: User:
Start: 09/30/11 End: 11/30/13 Due: 11/30/14

A Study to Test the Effect of Empagliflozin in Patients Who Are in Hospital for Acute Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT04157751 Org: User:
Start: 05/18/20 End: 06/02/21 Due: 06/02/22

Efficacy and Safety of 2 Doses of Tiotropium Via Respimat in Adult Patients With Mild Persistent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01316380 Org: User:
Start: 03/31/11 End: 04/30/12 Due: 04/30/13